E. Daiter et al., GONADOTROPIN-RELEASING HORMONE-DEPENDENT CHORIONIC-GONADOTROPIN SECRETION IN A MENOPAUSAL WOMAN, The Journal of clinical endocrinology and metabolism, 78(6), 1994, pp. 1293-1297
We report the evaluation of a 46-yr-old asymptomatic menopausal woman
whose serum hCG concentrations remained persistently supranormal for 3
yr (mean +/- SD, 20 +/- 10 IU/L; n = 19). Holo-hCG and beta-core frag
ments were detected in the patient's urine by Ultragel chromatography,
followed by specific RIAs. Trophoblastic, germ cell, and other malign
ancies appeared to be excluded by the absence of serum tumor markers a
nd imaging procedures of the pelvis, abdomen, breast, and chest. Admin
istration of a single bolus dose of synthetic GnRH (100 mu g) increase
d the serum hCG concentration by 50% (from 26 to 40 IU/L). Administrat
ion of the Nal-Glu GnRH antagonist (5 mg, sc, every 12 h for 1 week) d
ecreased the serum hCG concentration from 27 to 4.6 IU/ L. The pronoun
ced decrease in the serum hCG concentration during antagonism of the a
ction of endogenous GnRH by administration of Nal-Glu GnRH suggests th
at the pituitary is the source of the supranormal serum hCG concentrat
ions, because the pituitary is exposed to the highest concentration of
endogenous GnRH.